Pays: États-Unis
Langue: anglais
Source: NLM (National Library of Medicine)
ESTROGENS, CONJUGATED (UNII: IU5QR144QX) (ESTROGENS, CONJUGATED - UNII:IU5QR144QX)
Avera McKennan Hospital
ESTROGENS, CONJUGATED
ESTROGENS, CONJUGATED 0.9 mg
PRESCRIPTION DRUG
New Drug Application
PREMARIN- ESTROGENS, CONJUGATED TABLET, FILM COATED AVERA MCKENNAN HOSPITAL ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE PREMARIN SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR PREMARIN. PREMARIN® (CONJUGATED ESTROGENS) TABLETS, USP FOR ORAL USE INITIAL U.S. APPROVAL: 1942 WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER AND PROBABLE DEMENTIA _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ ESTROGEN-ALONE THERAPY THERE IS AN INCREASED RISK OF ENDOMETRIAL CANCER IN A WOMAN WITH A UTERUS WHO USES UNOPPOSED ESTROGENS (5.2) ESTROGEN-ALONE THERAPY SHOULD NOT BE USED FOR THE PREVENTION OF CARDIOVASCULAR DISEASE OR DEMENTIA (5.1, 5.3) WOMEN'S HEALTH INITIATIVE (WHI) ESTROGEN-ALONE SUBSTUDY REPORTED INCREASED RISKS OF STROKE AND DEEP VEIN THROMBOSIS (DVT) (5.1) THE WHI MEMORY STUDY (WHIMS) ESTROGEN-ALONE ANCILLARY STUDY OF WHI REPORTED AN INCREASED RISK OF PROBABLE DEMENTIA IN POSTMENOPAUSAL WOMEN 65 YEARS OF AGE AND OLDER (5.3) ESTROGEN PLUS PROGESTIN THERAPY ESTROGEN PLUS PROGESTIN THERAPY SHOULD NOT BE USED FOR THE PREVENTION OF CARDIOVASCULAR DISEASE OR DEMENTIA (5.1, 5.3) THE WHI ESTROGEN PLUS PROGESTIN SUBSTUDY REPORTED INCREASED RISKS OF STROKE, DVT, PULMONARY EMBOLISM (PE), AND MYOCARDIAL INFARCTION (MI) (5.1) THE WHI ESTROGEN PLUS PROGESTIN SUBSTUDY REPORTED INCREASED RISKS OF INVASIVE BREAST CANCER (5.2) THE WHIMS ESTROGEN PLUS PROGESTIN ANCILLARY STUDY OF WHI REPORTED AN INCREASED RISK OF PROBABLE DEMENTIA IN POSTMENOPAUSAL WOMEN 65 YEARS OF AGE AND OLDER (5.3) INDICATIONS AND USAGE PREMARIN is a mixture of estrogens indicated for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause (1.2) Treatment of Hypoestrogenism due to Hypogonadism, Castration or Primary Ovarian Failure (1.3) Treatment of Breast Cancer (for Palliation Only) in Appropriately Selected Women and Men with Metastatic Disease (1.4) Lire le document complet